NET PROFIT (x1000 SEK)
EMPLOYEES
Billev Pharma ApS
Closing information (x1000 SEK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
6,842
|
9,634
|
10,698 |
| Total assets |
10,891
|
13,590
|
14,357 |
| Current assets |
10,867
|
13,587
|
14,349 |
| Current liabilities |
3,990
|
3,394
|
3,410 |
| Equity capital |
5,829
|
7,995
|
8,775 |
| - share capital |
504
|
486
|
443 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
53.5%
|
58.8%
|
61.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
272.4%
|
400.3%
|
420.8% |
| Return on equity (ROE) |
117.4%
|
120.5%
|
121.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.